• Home
  • About

Patently BIOtech

Entries RSS | Comments RSS
  • Enter your email address to subscribe to this blog and receive notifications of new posts by email.

    Join 20 other followers
  • Recent Posts

    • Translational Research Forum at BIO International Convention
    • University-Industry Partnering at BIO Convention Webinar by AUTM June 16, 3-4PM
    • BIO has issued a strong letter of support for the Manager’s Amendment to H.R. 1249, the America Invents Act
    • Supreme Court Affirms: High Level of Proof Needed to Invalidate A Patent
    • Debunking the Myth: ‘Gene Patents’ are not necessary for healthcare innovation.
  • Categories

    • 2010 BIO International Convention
    • about the blog
    • Bayh-Dole
    • BIO Home Videos
    • Counterfeits
    • economic development
    • events
    • Evolving IP Market Place FTC
    • Follow-on Biologics
    • Gene Patents
    • Global Health
    • Green Technology
    • International
    • IP Counsels' Committee
    • IP News Weekly
    • NIH
    • Patent Reform
    • patents
    • Supreme Court
    • Sustainability
    • technology transfer
    • Twitter Twang
    • Uncategorized
    • United States Patent and Trademark Office
    • US Federal Circuit of Appeals
    • WIPO
  • Top Clicks

    • None
  • brought to you by
    Biotechnology Industry Organization
    1201 Maryland Ave., SW
    Washington, DC 20024
    202.962.9200
    www.bio.org

    terms of use
    privacy policy

Media Coverage of BIO’s Intellectual Property Conference in Seattle

Posted on April 20, 2011 by rzwahlen

Stanford v. Roche: An Academic/Industry Collaboration Gone Wrong

A Landmark Case: The Aftermath of Myriad Genetics

Ethical Issues: Staying in the Frying Pan and out of the Fire

Filed under: IP Counsels' Committee, Uncategorized | Tagged: Academic and industry collaboration, AMP v. USPTO, Gene Quinn, IP Ethics, IP Watchdog, Myriad, Stanford v. Roche | 1 Comment »

  • RSS Blogroll

    • An error has occurred; the feed is probably down. Try again later.
  • Access and Benefit Sharing ACLU America Invents Act AMP v. USPTO AUTM backlog Barack Obama Bayh-Dole Bayh-Dole Act BIO bio09 BIO Letter to the President biotechnology Biotechnology Industry Organization Brazil business model CBD Charles Grassley China clear and convincing evidence Convention on Biological Diversity David Kappos Department of Commerce developing countries DNA patents economic development economic growth emerging markets fee diversion First inventor to file First to file Follow-on Biologics FTC FTC report gene patenting gene patents Gene Quinn global health Green Technology healthcare reform humanitarian humanitarian technologies i4i Innovation intellectual property International IP News Weekly Jim Greenwood job creation job growth Lamar Smith Leahy licensing Microsoft Microsoft v. i4i Myriad Nagoya Protocol National Institutes of Health NIH patent Patent and Trademark Office Patent Office Patent Reform PTO R&D Research and Development Stanford v. Roche Supreme Court Sustainability technology transfer United Nations United States Patent and Trademark Office United States Patent Office US Federal Circuit of Appeals USPTO
  • Archives

    • June 2011
    • May 2011
    • April 2011
    • March 2011
    • February 2011
    • January 2011
    • December 2010
    • November 2010
    • October 2010
    • June 2010
    • May 2010
    • April 2010
    • March 2010
    • January 2010
    • November 2009
    • October 2009
    • August 2009
    • July 2009
    • June 2009
    • May 2009
    • April 2009
    • March 2009
    • February 2009
    • January 2009
    • November 2008

Create a free website or blog at WordPress.com. WP Designer.

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Follow Following
    • Patently BIOtech
    • Already have a WordPress.com account? Log in now.
    • Patently BIOtech
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar